Skip to main content

Table 6 ADME analysis of synthesized (E)-2-(3-(substitutedstyryl)-5-(substitutedphenyl)-4,5-dihydropyrazol-1-yl)benzo[d]thiazole derivatives by Pre ADMET online server

From: Synthesis, in silico studies and biological screening of (E)-2-(3-(substitutedstyryl)-5-(substitutedphenyl)-4,5-dihydropyrazol-1-yl)benzo[d]thiazole derivatives as an anti-oxidant, anti-inflammatory and antimicrobial agents

Comp

Human intestinal absorption (HIA, %)

In vitro Caco-2 cell permeability (nm/s)

In vitro MDCK cell permeability (nm/s)

In vitro plasma protein binding (%)

In vivo blood brain barrier penetration (C.brain/C. blood)

Pgp_inhibition

Z1

98.23

57.80

0.177

100

0.41

Inhibitor

Z2

98.23

57.03

28.85

97.62

0.82

Inhibitor

Z3

98.48

01.82

0.04

93.74

0.32

Inhibitor

Z4

98.48

01.08

0.04

94.60

0.52

Inhibitor

Z5

98.48

01.01

0.04

93.74

0.57

Inhibitor

Z6

98.23

56.83

12.79

97.67

0.51

Inhibitor

Z7

96.02

29.91

0.19

95.10

0.59

Inhibitor

Z8

96.02

39.58

0.04

95.28

0.44

Inhibitor

Z9

98.27

56.27

0.02

100

0.41

Inhibitor

Z10

97.95

38.08

0.37

93.08

0.80

Inhibitor

Z11

97.68

44.87

0.04

91.56

1.97

Inhibitor

Z12

97.86

37.63

63.42

94.17

2.18

Inhibitor

Z13

97.87

53.83

0.05

96.94

0.46

Inhibitor

Z14

97.68

34.80

1.32

91.32

3.62

Inhibitor

Z15

97.68

36.02

0.05

91.64

2.02

Inhibitor

Z16

98.35

56.16

0.02

100

0.74

Inhibitor

Z17

98.37

56.16

0.05

100

0.60

Inhibitor

Z18

98.37

56.64

0.07

100

0.60

Inhibitor

Z19

97.69

33.42

0.04

90.39

2.81

Inhibitor

Z20

98.27

36.86

0.04

90.12

2.41

Inhibitor

  1. Caco-2- Cells derived from human colon adenocarcinomas; MDCK- Medin-Darbey Canine Kidney Epithelial Cells; Pgp- P- glycoprotein (plasma membrane protein)